| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,574 |
10,068 |
$441K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,878 |
6,333 |
$369K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,851 |
2,769 |
$252K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,700 |
1,571 |
$220K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,265 |
2,198 |
$210K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,528 |
2,395 |
$208K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,219 |
1,907 |
$171K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,296 |
7,060 |
$168K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,490 |
4,182 |
$112K |
| 99429 |
|
2,192 |
2,046 |
$70K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,472 |
1,404 |
$41K |
| 99000 |
|
2,743 |
2,563 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,082 |
1,034 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,457 |
1,997 |
$21K |
| 90461 |
|
2,155 |
1,818 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,103 |
1,059 |
$15K |
| 92552 |
|
902 |
834 |
$15K |
| 0071A |
|
263 |
262 |
$11K |
| 0072A |
|
251 |
250 |
$10K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,163 |
999 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
120 |
114 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
461 |
445 |
$9K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
115 |
108 |
$9K |
| 0002A |
|
154 |
153 |
$6K |
| 0001A |
|
160 |
155 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
515 |
408 |
$6K |
| 87631 |
|
47 |
41 |
$5K |
| 96160 |
|
2,747 |
2,607 |
$5K |
| 83655 |
|
457 |
437 |
$5K |
| 99460 |
|
55 |
54 |
$4K |
| 0053A |
|
50 |
50 |
$2K |
| 87634 |
|
45 |
43 |
$2K |
| 94060 |
|
45 |
43 |
$2K |
| 87807 |
|
150 |
147 |
$2K |
| 90670 |
|
1,173 |
1,119 |
$2K |
| 90651 |
|
928 |
882 |
$1K |
| 0003A |
|
38 |
34 |
$1K |
| 90620 |
|
444 |
415 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| 0073A |
|
32 |
31 |
$1K |
| 0081A |
|
32 |
30 |
$1K |
| 90734 |
|
699 |
637 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
106 |
86 |
$1K |
| 99173 |
|
1,147 |
1,052 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
101 |
60 |
$998.56 |
| 81000 |
|
565 |
540 |
$788.06 |
| 90686 |
|
2,761 |
2,682 |
$786.57 |
| 90671 |
|
592 |
542 |
$738.61 |
| 90480 |
|
13 |
13 |
$443.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
244 |
188 |
$379.70 |
| 90680 |
|
1,198 |
1,121 |
$333.48 |
| 90633 |
|
895 |
835 |
$209.37 |
| 90648 |
|
1,288 |
1,200 |
$189.04 |
| 90716 |
|
152 |
144 |
$163.34 |
| 99001 |
|
25 |
23 |
$111.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$109.47 |
| 90707 |
|
157 |
148 |
$94.15 |
| 90698 |
|
203 |
193 |
$89.66 |
| 90723 |
|
780 |
739 |
$75.06 |
| 90715 |
|
217 |
197 |
$73.17 |
| 90696 |
|
181 |
162 |
$57.03 |
| 90700 |
|
183 |
160 |
$27.63 |
| 85014 |
|
15 |
14 |
$8.60 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
22 |
21 |
$3.07 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$0.34 |
| 91307 |
|
671 |
613 |
$0.17 |
| 90656 |
|
194 |
192 |
$0.08 |
| 90619 |
|
32 |
30 |
$0.05 |
| 91305 |
|
199 |
177 |
$0.03 |
| 91308 |
|
85 |
80 |
$0.03 |
| 90710 |
|
144 |
117 |
$0.01 |
| 91300 |
|
308 |
279 |
$0.01 |
| A4550 |
Surgical trays |
63 |
53 |
$0.00 |